AML residual disease

Two in three patients in complete remission from acute myeloid leukaemia still carry detectable leukaemia at the sequence level.1

Their five-year survival is 34%, against 68% for those who clear it.2

2 in 31
patients in complete remission still carry detectable leukaemia
34%2
five-year survival when it is still there
68%2
five-year survival for those who clear it

Remission should mean the leukaemia is gone, not that it has fallen below the resolution of a microscope.

Please note: Quorvix Labs operates in a stealth capacity.

Everything sent here is read by someone working on it. Details are held only so that we can answer. Privacy statement.